• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Andrew M. Goldsweig, MD

Latest:

Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.


Steven M. Kymes, PhD

Latest:

Association Among Change in Medical Costs, Level of Comorbidity, and Change in Adherence Behavior

The authors found that comorbidity burden and the direction of behavioral change influence the relationship between adherence and medical spend. This could affect the cost-benefit considerations of medication adherence programs.



Based on a presentation by Jay Hewitt

Latest:

Triathlete Pushes Limits of What's Possible With Type 1 Diabetes

A former triathlete and a T1DM patient, Jay Hewitt, was the special guest speaker at the PCDC 2014 meeting.


Robert A. Forbes, PhD

Latest:

Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression

Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.




Yuting Zhang, PhD

Latest:

Using a Modified Next Generation ACO Benchmark Can Improve the MSSP

The Medicare Shared Saving Program benchmark can be improved by following the example of Next Generation accountable care organizations, but with a larger adjustment level.


David M. Jackman, MD

Latest:

Lessons From the Front: Designing and Implementing Clinical Pathways by and for Clinicians

As cancer care becomes more complex and more expensive, decision-support algorithms offer a mechanism to define best practice, reduce unwarranted variation, and control costs across growing networks.





Allison L. Russell, BA

Latest:

Impact of Electronic Prescribing on Medication Use in Ambulatory Care

Both potential benefits and unexpected consequences were found as a result of the rollout of electronic prescribing.



Erin J. A. Bowles, MPH

Latest:

Evidence Gaps in Advanced Cancer Care: Community-Based Clinicians' Perspectives and Priorities for CER

Comparative effectiveness research and pragmatic clinical trials are valued methods to address the limitations of traditional randomized trials, answer questions of cost-effectiveness or noninferiority, and inform data-driven dialogue and decision making by stakeholders.


Rahul K. Khare, MD, MS

Latest:

Employer-Led Efforts to Improve the Value of Health Spending

Findings from a systematic review show that employer-led efforts to date have produced few promising strategies for improving the value of health spending.


Biao Xu, MD, PhD, MPH

Latest:

Type 2 Diabetes Mellitus in China: A Preventable Economic Burden

Treatment of type 2 diabetes mellitus and its complications places a heavy burden on healthcare budgets in China and will continue to do so.


Linda Dunbar, PhD

Latest:

Association of Care Management Intensity With Healthcare Utilization in an All-Condition Care Management Program

Higher intensity of care management in an all-condition program addressing care coordination and care barriers was associated with increased healthcare utilization among Medicaid and Medicare patients.


Steven E. Wegner, JD, MD

Latest:

A Physician-Friendly Alternative to Prior Authorization for Prescription Drugs

A policy allowing prescribers to write prior authorization criteria directly on the prescription led to decreased gaps in therapy without diminishing drug cost savings.


Cynthia Nakasato, MD*

Latest:

Hepatitis B Virus Infection Testing and Prevalence Among Asian and Pacific Islanders

We examined the effect of country of origin on HBV testing and chronic HBV infection prevalence among APIs using data from Kaiser Permanente Hawaii.


Lou Ann Thorsness, RPh

Latest:

A Randomized, Pragmatic, Pharmacist-Led Intervention Reduced Opioids Following Orthopedic Surgery

This pharmacist-led, patient-directed intervention demonstrated a reduction in opioid dispensings in the 90 days following hip replacement but not knee replacement.


Regina Grebla, PhD

Latest:

Treatment Patterns Among Adults With ADHD Receiving Long-Acting Therapy

Adults with attention-deficit/hyperactivity disorder (ADHD) who received long-acting combination therapy had significantly lower adherence and persistence compared with those who received long-acting monotherapy.




Jeffrey M. Pyne, MD

Latest:

A Web-Based Clinical Decision Support System for Depression Care Management

This article describes the development and capabilities of a Webbased decision support system for care managers working in the context of the chronic care model.



Daniel S. Longyhore, PharmD

Latest:

Lipid Profile Changes Associated With Changing Available Formulary Statins: Removing Higher Potency Agents

With the exception of high-density lipoprotein cholesterol, fasting lipid profiles were not significantly changed after higher potency statins were removed from prescription formularies.



Meghan H. Gabriel, PhD

Latest:

COPD Treatment Ratio: A Measure for Improving COPD Population Health

This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.